Orthopedic Funding Remains Strong Despite Slower Pace

Average Orthopedic Investment by Year

Orthopedic funding is on pace for its slowest year in the last decade, with just 20 funding announcements through October 2025. Since 2022, investors have looked to de-risk by preferentially seeking later-stage companies with a clear line of sight to commercialization.

Total investment dollars are...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.

ME

Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.



Contact Us

0